Abstract
Introduction
Ethics committees have been an integral part of clinical research since 1975, when they were introduced through the amendment of the Declaration of Helsinki. Every proposal for clinical research on human subjects has to be submitted to an independent ethics committee for review and approval. The European Clinical Trials Directive 2001/20/EC was implemented in 2004 to harmonise the legislative framework for clinical research in Europe in order to make Europe more competitive in clinical research while at the same time improving the protection of research participants.
Results
We have evaluated the situation of ethics committees in Europe five years after the implementation of the new law with special consideration of the number of Ethics Committees per European Member State and the number of members within the specific committees, including the selection of members, also in regard to gender aspects and training requirements, the remuneration or compensation of members in regard of their review obligations, and also issues of conflicts of interest.
Conclusion
Inadequate remuneration for professional services and gender imbalance are universal concerns across Europe. As the position of ethics committees changes continuously towards greater responsibility, further guidance is needed to uniformly adapt their structures to those needs.
Similar content being viewed by others
Notes
World Medical Association (2002) World Medical Association Declaration of Helsinki: Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects. Adopted by the 18th World Medical Assembly Helsinki, Finland, June 1964. Amended by the 29th World Medical assembly, Tokyo, Japan, October 1975; 35th World Medical Assembly, Venice, Italy, October 1983; 41st World Medical Assembly, Hongkong; 48th General Assembly, September 1989, Somerset West, Republic of South Africa, October 1996 and the 52nd General Assembly, Edinburgh, Scotland, October 2000 and the Note of Clarification on Paragraph 29 added by the World Medical Association General Assembly, Washington 2002.
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.
Sweden: The act on ethics review of research involving humans (2003:460).
ICREL final report, http://efgcp.be/ICREL/#report.
Recommendations with Gender Reference for Ethics committees and Clinical Studies; Opinion of the Bioethics Commission at the Federal Chancellery, Austria (15 Nov 2008) http://www.bundeskanzleramt.at/DocView.axd?CobId=33153.
References
EFGCP Ethics Working Party (2007) Subgroup on Ethics Committees reviewing investigational medicinal products within the European Union: the procedure for the ethical review of protocols for clinical research projects in the European Union. Int J Pharm Med 21:1–113 update 2008 (http://www.efgcp.be/html.asp?what=efgcpreport.htm&L1=5&L2=1#report)
Davies H, Wells F, Druml C (2008) How can we provide effective training for research ethics committees members? A European assessment. J Med Ethics 34:301–302
Wolzt M, Druml C, Leitner D, Singer EA (2009) Protocols in expedited review: tackling the workload of ethics committees. Intensive Care Med 35:613–615
Chassany O (2009) Should European Independent Ethics Committees be dismantled? Intensive Care Med 35:579–581
Moerman CJ, Haafkens JA, Söderström M (2007) Gender equality in the work of local research ethics committees in Europe: a study of practice in five countries. J Med Ethics 33:107–112
Druml C (2008) 30 Jahre Ethikkommission der Medizinischen Universität Wien: Garant für integre und transparente Forschung. Wien Klin Wochenschr 120:645–646
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Druml, C., Wolzt, M., Pleiner, J. et al. Research ethics committees in Europe: trials and tribulations. Intensive Care Med 35, 1636–1640 (2009). https://doi.org/10.1007/s00134-009-1544-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-009-1544-y